Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic β-adrenoreceptor activation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 4, 2007, Pages

  Osadchii, Oleg E ^a   Norton, Gavin R ^a,b   McKechnie, Richard ^a   Deftereos, Dawn ^a   Woodiwiss, Angela J ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

Cardiac remodeling; Contractility; Inotropic responses; Isoproterenol

Indexed keywords

BETA ADRENERGIC RECEPTOR; DNA NUCLEOTIDYLEXOTRANSFERASE; DOBUTAMINE; ISOPRENALINE; SALBUTAMOL;

ARTICLE; CELL DAMAGE; CONTROLLED STUDY; HEART CONTRACTION; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANIMALS; APOPTOSIS; CARDIOMYOPATHY, DILATED; DOBUTAMINE; DOWN-REGULATION; HEART FAILURE, CONGESTIVE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; NOREPINEPHRINE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34147120009     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00740.2006     Document Type: Article

References (38)

1. Agarwala S, Kalil RE. Axotomy-induced neuronal death and reactive astrogliosis in the lateral geniculate nucleus following a lesion of the visual cortex in the rat. J Comp Neurol 392: 252-263, 1998.
2. Anand IS. Ventricular remodeling without cellular contractile dysfunction. J Card Fail 8: S401-S408, 2002.
3. Badenhorst D, Veliotes D, Maseko M, Tsotetsi OJ, Brooksbank RL, Naidoo A, Woodiwiss AJ, Norton GR. β-Adrenergic activation initiates chamber dilatation in concentric hypertrophy. Hypertension 41: 499-504, 2003.
4. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 65: 657-670, 1989.
5. Bohm M, Rosee KL, Schwinger RHG, Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 25: 146-153, 1995.
6. Butterfield MC, Chess-Williams R. Potentiation of α-adrenoceptor-mediated responses following chronic β-adrenoceptor stimulation in the rat heart. Br J Pharmacol 108: 658-662, 1993.
7. Chang HY, Klein RM, Kunos G. Selective desensitization of cardiac beta-adrenoceptors by prolonged in vivo infusion of catecholamines in rats. J Pharmacol Exp Ther 221: 784-789, 1982.
8. Collins P, Billings CG, Barer GR, Daly JJ, Jolly A. Quantitation of isoprenaline-induced changes in the ventricular myocardium. Cardiovasc Res 9: 797-806, 1975.
9. Dhalla NS, Balasubramanian V, Goldman J. Biochemical basis of heart function. III. Influence of isoproterenol on the norepinephrine stores in the rat heart. Can J Physiol Pharmacol 49: 302-311, 1971.
10. Dong E, Yatani A, Mohan A, Liang C. Myocardial β-adrenoceptor down-regulation by norepinephrine is linked to reduced norepinephrine uptake activity. Eur J Pharmacol 384: 17-24, 1999.
11. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, Kopin IJ, Goldstein DS, Esler MD. Cardiac sympathetic nerve function in congestive heart failure. Circulation 93: 1667-1676, 1996.
12. Ganhao MF, Hattingh J, Hurwitz ML, Pitts NI. Evaluation of a simple plasma catecholamine extraction procedure prior to high-performance liquid chromatography and electrochemical detection. J Chromatogr 564: 55-66, 1991.
13. Grimm D, Elsner D, Schunkert H, Pfeifer M, Griese D, Bruckschlegel G, Muders F, Riegger GAJ, Kromer EP. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res 37: 91-100, 1998.
14. Hayes JS, Wyss VL, Schenck KS, Cohen ML. Effects of prolonged isoproterenol infusion on cardiac and vascular responses to adrenoceptor agonists. J Pharmacol Exp Ther 237: 757-763, 1986.
15. Himura Y, Felten SY, Kashiki M, Lewandowski TJ, Delehanty JM, Liang C. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure. Circulation 88: 1299-1309, 1993.
16. Kanoh M, Takemura G, Misao J, Hayakawa Y, Aoyamma T, Nishigashi K, Noda T, Fujiwara T, Fukuda K, Minatoguchi S, Fugiwara H. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy. Circulation 99: 2757-2764, 1999.
17. 1- and β-adrenoceptors. Eur J Pharmacol 67: 115-118, 1980.
18. Karliner JS, Alabaster C, Stephens H, Barness P, Dollery C. Enhanced noradrenaline response in cardiomyopathic hamsters: possible relation to changes in adrenoceptors studied by radioligand binding. Cardiovasc Res 15: 296-304, 1981.
19. Kleber FX, Niemoller I, Fischer M, Doering W. Influence of severity of heart failure on the efficacy of angiotensin-converting enzyme inhibition. Am J Cardiol 68: 121D-126D, 1991.
20. Lauer MS, Evans JC, Levy D. Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). Am J Cardiol 70: 1180-1184, 1992.
21. Lee TH, Hamilton MA, Stevenson LW, Moriguchi JD, Fonarow GC, Child JS, Laks H, Walden JA. Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol 72: 672-676, 1993.
22. Mueller RA, Axelrod J. Abnormal cardiac norepinephrine storage in isoproterenol-treated rats. Circ Res 23: 771-778, 1968.
23. Norton GR, Woodiwiss AJ, Gaasch WH, Mela T, Chung ES, Aurigemma GP, Meyer TE. Heart failure in pressure overload hypertrophy: the relative roles of ventricular remodeling and myocardial dysfunction. J Am Coll Cardiol 39: 664-671, 2002.
24. Osadchii O, Woodiwiss A, Alves N, Norton G. Mechanisms of preserved baseline cardiac systolic function in rats with adrenergic-inotropic- down-regulation. Life Sci 78: 366-375, 2005.
25. 2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res 92: 136-138, 2003.
26. Sahn DJ, De Maria A, Kisslo J, Weyman A. Recommendations regarding quantitation of M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978.
27. Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, Aakhus T. Heart volume and cardiovascular mortality: a 16 year follow-up study of 1984 healthy middle-aged men. Eur Heart J 14: 592-596, 1993.
28. Shizukuda Y, Buttrick PM, Geenen DL, Borczuk AC, Kitsis RN, Sonnenblick EH. β-Adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol Heart Circ Physiol 275: H961-H968, 1998.
29. 2- adrenoceptor-mediated positive inotropic effects in human end-stage heart failure. Br J Pharmacol 105: 463-469, 1992.
30. Suzuki M, Ohte N, Wang ZM, Williams DL, Little WC, Cheng CP. Altered inotropic response to endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy. Cardiovasc Res 39: 589-599, 1998.
31. Teerlink JR, Pfeffer JM, Pfeffer MA. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ Res 75: 105-113, 1994.
32. Unverferth DV, Magorien DR, Moeschberger MI, Baker PB, Fetters JK, Leier CV. Factors influencing the one year mortality of dilated cardiomyopathy. Am J Cardiol 54: 147-152, 1984.
33. 1-adrenergic receptors on sarcolemma from normal subjects and patients with idiopathic dilated cardiomyopathy: characteristics and linkage to GTP-binding protein. Circ Res 64: 474-481, 1989.
34. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 336: 1350-1355, 1997.
35. Veliotes DG, Woodiwiss AJ, Deftereos DA, Gray D, Osadchii O, Norton GR. Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation. Hypertension 45: 914-920, 2005.
36. Weber KT, Janicki J, Schroff SG, Pick R, Chen RM, Abrahams G, Bashey RI. Collagen remodeling of the pressure-overloaded hypertrophied non-human primate myocardium. Circ Res 62: 757-765, 1988.
37. Wong M, Johnson G, Shabetai R, Hughes V, Bhat G, Lopez B, Cohn JN. Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure: Veterans Affairs Cooperative Studies Ve-HeFT I and II. V-HeFT VA Cooperative Studies Group. Circulation 87: VI65-VI70, 1993.
38. Woodiwiss AJ, Tsotetsi OJ, Sprott S, Lancaster EJ, Mela T, Chung ES, Meyer TE, Norton GR. Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation 103: 155-160, 2001.